Showing results (531-540 of 1,112) with videos related to

Sort By:
Pageof 112
Stroke|December 22, 2007
Factors associated with the decision to hospitalize patients after transient ischemic attack before publication of prediction rulesS Andrew Josephson, Stephen Sidney, Trinh N Pham, et al.
Human Pathology|October 1, 1993
Cytogenetic studies of composite lymphomas: monocytoid B-cell lymphoma and other B-cell non-Hodgkin's lymphomasM L Slovak, L M Weiss, B N Nathwani, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|September 1, 1984
Intact and carboxyterminal PTH do not cross the blood-cerebrospinal fluid barrierM Akmal, S Tuma, D A Goldstein, et al.
The American Journal of Emergency Medicine|December 3, 2014
A randomized controlled trial of capnography during sedation in a pediatric emergency settingMelissa L Langhan, Veronika Shabanova, Fang-Yong Li, et al.
Stroke|August 9, 2008
Higher ABCD2 score predicts patients most likely to have true transient ischemic attackS Andrew Josephson, Stephen Sidney, Trinh N Pham, et al.
The American Journal of Emergency Medicine|September 10, 2010
Urgent neurology consultation from the ED for transient ischemic attackAnthony S Kim, Stephen Sidney, Allan L Bernstein, et al.
The Journal of Allergy and Clinical Immunology|January 1, 1990
Assessment of airway hyperresponsiveness in chronic stable asthmaS M Brooks, I L Bernstein, P K Raghuprasad, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 1, 1996
Risk factors for in situ breast cancerM P Longnecker, L Bernstein, A Paganini-Hill, et al.
The American Journal of Cardiology|August 1, 1983
Coronary and left ventricular angiographic anatomy and prognosis of survivors of first acute myocardial infarctionR D Abraham, G S Roubin, P J Harris, et al.
Clinical and Experimental Immunology|July 16, 2010
Developing combination immunotherapies for type 1 diabetes: recommendations from the ITN-JDRF Type 1 Diabetes Combination Therapy Assessment GroupJ B Matthews, T P Staeva, P L Bernstein, et al.
Pageof 112